INCA033989: the first shot on goal for MPNs?

In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs), inhibiting its oncogenic activity without affecting normal hematopoiesis.

Authors

Camélia Benlabiod (ORCID: https://orcid.org/0000-0001-7119-9326)
Bethan Psaila (ORCID: https://orcid.org/0000-0001-8198-9663)

Institutions

University of Oxford (GB)
Oxford University Hospitals NHS Trust (GB)

Publication Details

Journal: Blood
Published: 2024-11-28
DOI: https://doi.org/10.1182/blood.2024026811
Citations: 3
Primary Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 1.31

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

INCA033989: the first shot on goal for MPNs?

Camélia Benlabiod, Bethan Psaila

Nov 28, 2024

3 citations

Blood

Myeloproliferative Neoplasms: Diagnosis and Treatment

1.31

article

INCA033989: the first shot on goal for MPNs?

Camélia Benlabiod, Bethan Psaila

November 28, 2024article en

3 citations

Abstract

BloodVol. 144(22)

University of Oxford (GB), Oxford University Hospitals NHS Trust (GB)

Zero hunger

Openalex Percentile: Top 17%

Myeloproliferative Neoplasms: Diagnosis and Treatment

1.31

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

INCA033989: the first shot on goal for MPNs? — Camélia Benlabiod, Bethan Psaila · Blood (2024) | TGRS Research Map | TGRS